IMMR

Paris, France Founded: 2003 • Age: 23 yrs Acquired By Veranex
Preclinical research services are offered to MedTech and Biotech firms.

About IMMR

IMMR is a company based in Paris (France) founded in 2003, and was acquired by Veranex in October 2021. Preclinical research services are offered to MedTech and Biotech firms. Its legal entity is IMM RECHERCHE.

Company details

Founded in 2003 and based in Paris, France, IMMR operates in the preclinical research sector for MedTech and Biotech companies. Studies are conducted in large animal models within FDA-inspected facilities, covering early feasibility to GLP levels for global regulatory support. Expertise is applied in complex cardiovascular procedures and non-cardiovascular disease areas. In-house pathology services are provided, along with facilities enabling real-time, interactive observation for virtual study participation and training.

Key Metrics

Investors in IMMR

IMMR has secured backing from 1 investor. Prominent investors backing the company include Veranex.

All
InvestorDescriptionFounded YearDomainLocation
Veranex is recognized as an Innovation CRO specializing in medical device and diagnostic development.
veranexsolutions.comRaleigh, United States
Premium access

Investor details for IMMR

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of IMMR

2 dated milestones of IMMR across 18 years, from founding to its latest funding, stage changes and deals.

  1. Founded IMMR is founded.
  2. Exit Acquired by Veranex.

Web traffic of IMMR

The website of IMMR (imm-recherche.com) receives about 3.2K visits a month.

  • Monthly visits
    3.2K

    ▲ 187.1% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about IMMR

IMMR was founded in 2003.

IMMR is headquartered in Paris, France.

Founded in 2003 and based in Paris, France, IMMR operates in the preclinical research sector for MedTech and Biotech companies. Studies are conducted in large animal models within FDA-inspected facilities, covering early feasibility to GLP levels for global regulatory support. Expertise is applied in complex cardiovascular procedures and non-cardiovascular disease areas. In-house pathology services are provided, along with facilities enabling real-time, interactive observation for virtual study participation and training.

IMMR has 1 investor. Key investors include Veranex.

IMMR operates through Imm Recherche.

Yes. IMMR was acquired by Veranex in October 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available